Nestle CEO says Middle East conflict driving inflation, higher supplier costs

Nestle is raising prices, reformulating products and discontinuing items consumers will not absorb higher prices for as Middle East conflict-related energy, freight and raw-material inflation raises supplier costs. Its direct Middle East sales exposure is limited at roughly 2%-3% of approximately CHF90 billion ($111 billion) revenue, but the FAO Food Price Index rose to 131.1 in July from 130.3 in June, its highest level since January 2023. Nestle is streamlining around core brands through bottled-water and vitamins exits while remaining open to strategic acquisitions, and is pushing for industry input on proposed Indian front-of-pack nutrition warning labels.

Analysis

The relevant earnings risk is not direct regional exposure but a renewed pricing-volume tradeoff. Nestle can protect gross margin through price, pack-size and SKU actions, yet the marginal consumer response typically appears with a one-to-two quarter lag as retailers reset shelves and private-label substitution increases. Rationalizing low-elasticity SKUs should help mix and working capital, but it also lowers reported volume growth and leaves less room to absorb a further commodity shock without another round of pricing.

Portfolio simplification raises the importance of execution in the remaining core categories: a smaller non-core asset base can improve returns on capital, but disposal proceeds deployed into acquisitions at elevated branded-food multiples would dilute the intended margin and focus narrative. India is a medium-term asymmetric risk; prescriptive front-of-pack labeling could force reformulation, promotional spending, or category mix pressure across multinational packaged-food peers, with the regulatory template potentially extending beyond one market.

Consensus may underweight the lagged elasticity risk because defensive-staples demand holds initially during inflation episodes. We would not chase an outright short on this item alone: the more probable near-term outcome is multiple stagnation rather than a sharp earnings reset. The bearish thesis is falsified if upcoming results show organic growth holding while underlying trading operating margin expands despite higher input-cost guidance; conversely, a second consecutive guidance downgrade or materially negative real internal growth would validate a more active underweight.

Key Decisions for Investors

• Maintain an underweight in NESN/NSRGY versus the global staples basket over the next 1-3 months; use any relief rally following pricing commentary to add. Target is relative multiple compression if volume deterioration emerges, with the position invalidated by organic growth resilience plus margin expansion at the next earnings update.
• Establish a modest long DBA or a basket of coffee/cocoa/agricultural-input hedges only if the FAO index and freight benchmarks continue higher for 4-6 weeks; this is a hedge against sector-wide gross-margin pressure rather than a standalone directional commodity call. Exit if commodity inflation rolls over or consumer-staples companies demonstrate successful pass-through without volume losses.
• Monitor NESN's next results for price versus real internal growth, SKU-reduction savings, and capital-allocation detail. A negative volume surprise combined with acquisition announcements would be a trigger to increase the underweight; absent those data, avoid forcing a high-conviction short.
• Watch Indian labeling developments over the next 6-18 months as a regulatory-risk basket signal for NESN, UL and MDLZ. Consider reducing exposure to high-sugar/salt packaged-food categories if a mandatory warning-label framework advances from consultation to implementation.